3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
13
Breast Neoplasms
11
Carcinoma, Transitional Cell
6
Carcinoma, Non-Small-Cell Lung
5
Urinary Bladder Neoplasms
4
Neoplasm Metastasis
4
Lung Neoplasms
3
Small Cell Lung Carcinoma
2
Urothelial Bladder Carcinoma
1
Salivary Gland Neoplasms
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm, Residual
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Metastatic Urothelial Cancer
1
Lung Diseases
1
Locally Advanced or Metastatic Unresectable Urothelial Cancer
1
Localized Muscle Invasive Bladder Urothelial Carcinoma
1
Liver Failure
1
HRD Cancer
1
Glioblastoma
1
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
1
Drug-Related Side Effects and Adverse Reactions
1
Carcinoma, Small Cell
1
Brain Neoplasms
1
Advanced Solid Tumors
1
Interventions
Cisplatin
22
Magnetic Resonance Spectroscopy
15
Specimen Handling
13
Platinum
12
Radiotherapy, Intensity-Modulated
11
1,2-diaminocyclohexaneplatinum II citrate
11
Radiotherapy
10
Radiation
10
Carboplatin
9
Surveys and Questionnaires
5
Biopsy
5
pembrolizumab
4
Taxes
4
Paclitaxel
4
Nivolumab
4
Docetaxel
4
Chemoradiotherapy
4
Cetuximab
4
Observation
3
Fluorodeoxyglucose F18
3
(225)Ac-DOTA-c(RGDyK)
3
durvalumab
2
X-Rays
2
Watchful Waiting
2
Standard of Care
2
Radiotherapy, Image-Guided
2
Interviews as Topic
2
Immunoglobulin G
2
Fluorouracil
2
Disulfides
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Oropharyngeal Neoplasms
×
sacituzumab govitecan
×
90 days
×
Clear all
No trials found.